Lifeway Foods, Inc. reported significant financial growth in its latest quarterly filing, with net sales reaching $57.1 million for the three months ended September 30, 2025, marking a 24% increase from $46.1 million in the same period last year. For the nine-month period, net sales totaled $157.1 million, up 12.3% from $139.9 million in 2024. The increase in revenue was primarily driven by higher volumes of branded drinkable kefir, despite some challenges related to customer relationships and distribution shifts that impacted sales in the previous year.
The company's gross profit for the third quarter was $16.4 million, representing 28.7% of net sales, compared to 25.7% in the prior year. This improvement was attributed to increased manufacturing efficiencies and favorable pricing for conventional milk. However, total operating expenses also rose, with selling expenses increasing to $5.0 million and general and administrative expenses rising to $6.2 million, largely due to professional fees associated with an unsolicited purchase proposal from Danone and other non-routine actions.
In terms of operational metrics, Lifeway's total current assets increased to $53.8 million as of September 30, 2025, up from $43.6 million at the end of 2024. The company also reported a rise in inventories to $11.1 million, reflecting its strategy to bolster production capabilities. Lifeway's employee headcount remained stable, with 15.2 million shares of common stock outstanding as of November 6, 2025. The company continues to focus on expanding its market share in the cultured dairy segment, particularly through its flagship drinkable kefir products.
Strategically, Lifeway has made moves to enhance its supply chain by purchasing 402 mature dairy cows to secure a more reliable source of organic milk. This initiative is part of a broader effort to increase production capacity and meet growing consumer demand for organic products. The company has entered into a five-year agreement with a third-party dairy facility to manage the herd, which is expected to yield monthly payments starting December 2025.
Looking ahead, Lifeway remains optimistic about its growth trajectory, anticipating continued demand for its health-focused products amid a growing consumer interest in wellness. The company has sufficient liquidity, with $25 million available under its revolving credit facility, and expects to leverage its financial position to support ongoing operational and capital needs. Lifeway's management is committed to navigating market challenges while capitalizing on opportunities for expansion and innovation in the cultured dairy market.
About Lifeway Foods, Inc.
Lifeway Foods, Inc. is a leading producer of kefir and probiotic dairy products in the U.S., offering drinkable kefir, cheeses, yogurt, and other dairy items. Serving primarily North American markets, it emphasizes product innovation, quality, and brand recognition. The company operates manufacturing facilities, leverages direct and distributor sales channels, and competes through marketing and product differentiation in the functional foods and health-conscious segments.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.